Ford: Analysts' Upgrades, Downgrades

Ford downgraded at Credit Suisse, numbers raised at Barclays and UBS.
By TSC Staff ,

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

ACE Limited

(ACE)

upgraded at Citi to Buy and added to Top Picks Live. Superior reserve/capacity profile and upside potential with A&H business. Price target raised to $64.

Ametek

(AME) - Get Report

upgraded at Baird from Neutral to Outperform. Company reported a strong quarter. $49 price target.

Ashland

(ASH) - Get Report

upgraded at Longbow from Neutral to Buy. Estimates also boosted, given price increases. $75 price target.

Bill Barrett Corp

(BBG)

upgraded at Barclays to Overweight from Equal Weight on valuation. Perception that the company's Rockies project could be pressured in current price environment. Price target increased to $43 from $38.

Dell

(DELL) - Get Report

downgraded at UBS from Buy to Neutral. Valuation call, as the stock is up 25% in the past two months. $17.50 price target.

Domino's Pizza

(DPZ) - Get Report

downgraded at Citi to Hold from Buy on valuation and high expectations. Price target raised by a dollar to $19.50. 2010 and 2011 EPS estimates lifted to $1.30 and $1.41, respectively.

Davita

(DVA) - Get Report

downgraded at Jefferies from Buy to Hold. $69 price target. Multiple potential negative catalysts lie ahead.

Ford

(F) - Get Report

downgraded at Credit Suisse to Underperform from Neutral. Profit levels have red-lined, time to down-shift. Maintain $10 price target.

Ford

(F) - Get Report

target, estimates raised at Barclays. F price target inched higher to $13 from $12 on solid 1Q10 beat. 2010 and 2011 EPS estimates lifted to $1.57 and $1.85, respectively. Equal Weight rating.

Ford

(F) - Get Report

estimates increased at UBS through 2011. Company is seeing better results for credit and in Europe. Buy rating and $16 price target.

Forest Oil

(FST)

downgraded at Barclays to Equal Weight from Overweight based on recent share performance.

3M

(MMM) - Get Report

estimates, target upped at UBS. MMM estimates were boosted through 2011. Company is seeing better organic growth. Buy rating and new $110 price target.

3M

(MMM) - Get Report

upgraded at Barclays to Overweight from Equal Weight on better than expected 1Q10 results. Price target jumped to $105 from $90. Estimates raised through 2012.

More Market News

Dow Holds Gains After Spain Rate Cut

NBTY

(NTY)

upgraded at Barclays to Overweight from Equal Weight. The company's results showed that it will hurt the short-term to benefit the long-term. Price target increased to $46 from $44. 2010 EPS estimate cut to $3.76, 2011 raised to $4.53.

Pride International

(PDE)

upgraded at Credit Suisse to Outperform from Neutral. Higher forecasts, new contract opportunities, and ongoing cost cutting. Price target raised to $38 from $30.

Progress Energy

(PGN)

rated new Hold at Deutsche. $39 price target. Company still faces challenges in Florida.

Savvis

(SVVS)

downgraded at Morgan Stanley from Overweight to Equal-weight. Valuation call, as the stock is up 32% year-to-date.

Tellabs

(TLAB)

upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $11.00 from $8.50. 2010 EPS estimates raised to $0.51 from $0.36.

United Parcel

(UPS) - Get Report

upgraded at Morgan Stanley from Underweight to Equal-weight. Company reported a strong quarter and trades at a reasonable valuation.

Watson Pharmaceuticals

(WPI)

upgraded at Goldman from Sell to Neutral. Estimates also boosted, given recent product approvals and higher expected cost savings.

Cimarex Energy

(XEC) - Get Report

upgraded at Barclays. XEC upgraded to Overweight from Equal Weight based on the company's strong balance sheet and prospects for further volume gains. Price target boosted to $93 from $70.

STOCK COMMENTS / EPS CHANGES

BE Aerospace

(BEAV)

estimates, target increased at FBR through 2011. Company boosted guidance. Outperform rating and new $38 price target.

Broadcom

(BRCM)

estimates, target increased at UBS. BRCM estimates were raised through 2011. Company is seeing better wireless growth. Neutral rating and new $39 price target.

Boston Scientific

(BSX) - Get Report

estimates cut at Morgan Stanley. BSX estimates were reduced through 2011. Company still stands to lose market share. Overweight rating and $10 price target.

Choice Hotels

(CHH) - Get Report

numbers increased at FBR through 2011. Fee-based model is driving growth. Outperform rating and new $42 price target.

Cummins

(CMI) - Get Report

target, estimates boosted at Barclays. CMI price target surged to $95 from $74. 1Q10 beat highlighted by a strong emerging markets position. 2010 and 2011 EPS estimates lifted to $4.15 and $5.75, respectively. Overweight rating.

Cummins

(CMI) - Get Report

estimates, target boosted at UBS. Shares of CMI now seen reaching $98. Estimates also upped, as the company is realizing higher margins. Buy rating.

CVS Caremark

(CVS) - Get Report

numbers boosted at UBS. Shares of CVS now seen reaching $46. Estimates also upped, given better PBM trends. Buy rating.

DuPont

(DD) - Get Report

price target increased at BofA/Merrill to $44 from $40. Raising numbers on broad-based volume strength.

DuPont

(DD) - Get Report

estimates, target raised at UBS. Shares of DD now seen reaching $47. Estimates also increased, to match the company's new guidance. Buy rating.

Flextronics

(FLEX) - Get Report

estimates, target raised at UBS. Shares of FLEX now seen reaching $9.50. Estimates also increased, because of the company's new guidance. Buy rating.

Home Depot

(HD) - Get Report

price target boosted at Citi. HD price target jumped to $43 from $34 as Spring selling season is off to a stronger-than-expected start. Estimates raised through 2012. Buy rating.

Health Management

(HMA)

price target higher at BofA/Merrill. HMA price target raised by fifty cents to $11 after strong results. Story on track for out Top Pick. Estimates raised through 2012. Buy rating.

Jacobs Engineering

(JEC) - Get Report

numbers raised at UBS. Shares of JEC now seen reaching $50. Estimates also increased, to match the company's new guidance. Neutral rating.

Kellogg

(K) - Get Report

estimates lowered at UBS through 2011. Company is seeing declining volume trends. Buy rating and $61 price target.

Kansas City Southern

(KSU) - Get Report

numbers upped at UBS through 2011. Company is paying down debt and has strong earnings momentum. Outperform rating and new $50 price target.

Life Technologies

(LIFE) - Get Report

numbers upped at Morgan Stanley through 2012. Company is seeing higher organic growth and margin expansion. Overweight rating and new $58 price target.

Lexmark

(LXK)

target, estimates higher at Citi. LXK price target increased to $56 from $52. 2010 and 2011 EPS estimates raised to $4.49 and $5.02, respectively. Reiterate Buy rating, but removing from Top Picks Live.

Macy's

(M) - Get Report

estimates, target boosted at Goldman. Shares of M now seen reaching $28. Estimates also upped, as the company is seeing higher sales. Neutral rating.

Molex

(MOLX)

estimates, target increased at UBS. MOLX estimates were raised through 2011. Company boosted its forward guidance. Neutral rating and new $24 price target.

Norfolk Southern

(NSC) - Get Report

price target raised at BofA/Merrill. NSC price target lifted to $64 from $61 as top line and cost controls drive EPS beat. Estimates increased through 2011. Neutral rating.

Norfolk Southern

(NSC) - Get Report

numbers boosted at FBR. Shares of NSC now seen reaching $66. Estimates also upped, as the company is posting higher volumes and yields. Market Perform rating.

RF Micro

(RFMD)

estimates, target boosted at UBS. Shares of RFMD now seen reaching $6.50. Estimates also upped, as the company continues to execute and see better bookings. Buy rating.

Torchmark

(TMK)

estimates, target raised at FBR. Shares of TMK now seen reaching $61. Estimates also increased, as the company is seeing better underwriting results. Outperform rating.

Under Armour

(UA) - Get Report

estimates, target raised at FBR. Shares of UA now seen reaching $34. Estimates also increased, given the company's new guidance. Market Perform rating.

U.S. Steel

(X) - Get Report

estimates, target raised at Goldman. Shares of X now seen reaching $73. Estimates also increased, as the company is seeing growth across the board. Buy rating.

Cimarex Energy

(XEC) - Get Report

numbers boosted at Morgan Stanley. Shares of XEC now seen reaching $80. Estimates also upped, as the company should see a higher multiple. Overweight rating.

This article was written by a staff member of TheStreet.com.

Loading ...